Aspirin use for the primary prevention of coronary heart disease: A population-based study in Switzerland

Individuals at intermediate CHD risk and diabetics are more likely to take aspirin, but there are significant opportunities for improvement. The underuse of aspirin for those at risk coexists with an overuse among those at low risk.